A. Vandercammen

1.1k total citations
18 papers, 897 citations indexed

About

A. Vandercammen is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A. Vandercammen has authored 18 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A. Vandercammen's work include Pancreatic function and diabetes (11 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diet, Metabolism, and Disease (8 papers). A. Vandercammen is often cited by papers focused on Pancreatic function and diabetes (11 papers), Metabolism, Diabetes, and Cancer (11 papers) and Diet, Metabolism, and Disease (8 papers). A. Vandercammen collaborates with scholars based in Belgium, France and Germany. A. Vandercammen's co-authors include Emile Van Schaftingen, Michel Detheux, Jean François, H G Hers, Dewi R. Davies, Daniël Pipeleers, Harry Heimberg, A. De Vos, F. Schuit and Willy Malaisse and has published in prestigious journals such as The EMBO Journal, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

A. Vandercammen

18 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Vandercammen Belgium 14 562 556 309 153 122 18 897
Yanhua Yan China 12 274 0.5× 328 0.6× 267 0.9× 27 0.2× 193 1.6× 32 807
Yeonhee Hong South Korea 16 247 0.4× 71 0.1× 77 0.2× 207 1.4× 50 0.4× 26 600
Jaleh Malakooti United States 20 665 1.2× 268 0.5× 34 0.1× 88 0.6× 244 2.0× 33 927
Youichi Sato Japan 18 366 0.7× 87 0.2× 297 1.0× 78 0.5× 236 1.9× 64 1.0k
Dongsheng Guo China 16 521 0.9× 86 0.2× 58 0.2× 79 0.5× 93 0.8× 41 803
Varsha Singh United States 17 429 0.8× 169 0.3× 37 0.1× 77 0.5× 107 0.9× 39 775
Xiaochun Tang China 20 594 1.1× 111 0.2× 46 0.1× 115 0.8× 325 2.7× 55 993
Helga Rothe Germany 14 162 0.3× 117 0.2× 73 0.2× 104 0.7× 142 1.2× 27 757
Obaid Ullah Beg United States 13 297 0.5× 94 0.2× 143 0.5× 23 0.2× 182 1.5× 28 647
Véronique Converset Switzerland 9 315 0.6× 75 0.1× 28 0.1× 132 0.9× 59 0.5× 9 499

Countries citing papers authored by A. Vandercammen

Since Specialization
Citations

This map shows the geographic impact of A. Vandercammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Vandercammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Vandercammen more than expected).

Fields of papers citing papers by A. Vandercammen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Vandercammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Vandercammen. The network helps show where A. Vandercammen may publish in the future.

Co-authorship network of co-authors of A. Vandercammen

This figure shows the co-authorship network connecting the top 25 collaborators of A. Vandercammen. A scholar is included among the top collaborators of A. Vandercammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Vandercammen. A. Vandercammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stosch, Moritz von, et al.. (2020). Working within the Design Space: Do Our Static Process Characterization Methods Suffice?. Pharmaceutics. 12(6). 562–562. 20 indexed citations
2.
Hermand, Philippe, A. Vandercammen, Emmanuel Mertens, et al.. (2016). Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen. Human Vaccines & Immunotherapeutics. 13(1). 220–228. 20 indexed citations
3.
Weynants, Vincent, Philippe Denoël, Nathalie Devos, et al.. (2009). Genetically Modified L3,7 and L2 Lipooligosaccharides from Neisseria meningitidis Serogroup B Confer a Broad Cross-Bactericidal Response. Infection and Immunity. 77(5). 2084–2093. 38 indexed citations
4.
Lange, Maria João Pimenta, A. Vandercammen, J. P. Dufour, & Yvan Larondelle. (1995). Determination of S-Adenosyl-L-Methionine: L-Methionine S-Methyltransferase Activity by Selective Adsorption of (methyl-3H)S-Adenosylmethionine onto Activated Charcoal. Analytical Biochemistry. 225(1). 167–169. 5 indexed citations
5.
Heimberg, Harry, A. De Vos, A. Vandercammen, et al.. (1993). Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport.. The EMBO Journal. 12(7). 2873–2879. 139 indexed citations
6.
Vandercammen, A. & Emile Van Schaftingen. (1993). Species and tissue distribution of the regulatory protein of glucokinase. Biochemical Journal. 294(2). 551–556. 72 indexed citations
7.
Schaftingen, Emile Van, A. Vandercammen, Michel Detheux, & Dewi R. Davies. (1992). The regulatory protein of liver glucokinase. Advances in Enzyme Regulation. 32. 133–148. 67 indexed citations
8.
Schaftingen, Emile Van & A. Vandercammen. (1992). Mechanism of the stimulatory effect of a potassium‐rich medium on the phosphorylation of glucose in isolated rat hepatocytes. European Journal of Biochemistry. 204(1). 363–369. 7 indexed citations
9.
Vandercammen, A., Michel Detheux, & Emile Van Schaftingen. (1992). Binding of sorbitol 6-phosphate and of fructose 1-phosphate to the regulatory protein of liver glucokinase. Biochemical Journal. 286(1). 253–256. 33 indexed citations
10.
Detheux, Michel, A. Vandercammen, & Emile Van Schaftingen. (1991). Effectors of the regulatory protein acting on liver glucokinase: a kinetic investigation. European Journal of Biochemistry. 200(2). 553–561. 62 indexed citations
11.
Vandercammen, A. & Emile Van Schaftingen. (1991). Competitive inhibition of liver glucokinase by its regulatory protein. European Journal of Biochemistry. 200(2). 545–551. 73 indexed citations
12.
Vandercammen, A., et al.. (1990). Fructose 2,6-bisphosphate and carbohydrate metabolism during the life cycle of the aquatic fungus Blastocladiella emersonii. Journal of General Microbiology. 136(1). 137–146. 31 indexed citations
13.
Vandercammen, A. & Emile Van Schaftingen. (1990). The mechanism by which rat liver glucokinase is inhibited by the regulatory protein. European Journal of Biochemistry. 191(2). 483–489. 90 indexed citations
14.
Malaisse, Willy, F Malaisse-Lagae, Dewi R. Davies, A. Vandercammen, & Emile Van Schaftingen. (1990). Regulation of glucokinase by a fructose‐1‐phosphate‐sensitive protein in pancreatic islets. European Journal of Biochemistry. 190(3). 539–545. 57 indexed citations
15.
Schaftingen, Emile Van & A. Vandercammen. (1990). A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate. Clinical Nutrition. 9(1). XIII–XIII. 1 indexed citations
16.
Vandercammen, A. & Emile Van Schaftingen. (1990). Stimulation of glucose phosphorylation by fructose in isolated rat hepatocytes. Clinical Nutrition. 9(1). XIII–XIII. 2 indexed citations
17.
Vandercammen, A., Jean François, & H G Hers. (1989). Characterization of trehalose‐6‐phosphate synthase and trehalose‐6‐phosphate phosphatase of Saccharomyces cerevisiae. European Journal of Biochemistry. 182(3). 613–620. 106 indexed citations
18.
Schaftingen, Emile Van & A. Vandercammen. (1989). Stimulation of glucose phosphorylation by fructose in isolated rat hepatocytes. European Journal of Biochemistry. 179(1). 173–177. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanhua Yan Breakdown of academic impact, for papers by Yeonhee Hong Breakdown of academic impact, for papers by Jaleh Malakooti Breakdown of academic impact, for papers by Youichi Sato Breakdown of academic impact, for papers by Dongsheng Guo Breakdown of academic impact, for papers by Varsha Singh Breakdown of academic impact, for papers by Xiaochun Tang Breakdown of academic impact, for papers by Helga Rothe Breakdown of academic impact, for papers by Obaid Ullah Beg Breakdown of academic impact, for papers by Véronique Converset
Rankless by CCL
2026